ISOLATION OF ENDOTHELIAL PROGENITOR CELL FROM HUMAN UMBILICAL CORD BLOOD

从人脐带血中分离内皮祖细胞

基本信息

  • 批准号:
    11557058
  • 负责人:
  • 金额:
    $ 8.64万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Endothelial precursor cells (EPCs) have been identified in adult peripheral blood. We examined whether EPCs could be isolated from Umbilical cord blood, a rich source for hematopoietic progenitors, and whether in vivo transplantation of EPCs could modulate postnatal neovascularization. Numerous cell clusters, spindle-shaped and attaching (AT) cells, and cord-like structures developed from culture of cord blood mononuclear cells (MNCs). Fluorescence-trace experiments revealed that cell clusters, AT cells and cord-like structures predominantly derived from CD34-positive MNCs (MNC^<CD34+>). Greater numbers of AT cells and cell clusters developed from cord blood-MNCs than from an equal amount of adult peripheral blood-MNCs. AT cells incorporated acetylated-LDL, released nitric oxide, and expressed KDR, VE-cadherin, CD31, and von Willebrand factor but not CD45. Locally transplanted AT cells survived and participated in capillary networks in the ischemic tissues of immunodeficient nude rats in vivo. AT cells thus had multiple endothelial phenotypes and were defined as a major population of EPCs. Furthermore, laser Doppler and immunohistochemical analyses revealed that EPC transplantation quantitatively augmented neovascularization and blood flow in the ischemic hindlimb. In conclusion, umbilical cord blood is a precious source for isolating EPCs, and transplantation of cord blood-derived EPCs would be a novel strategy to modulate postnatal neovascularization.
内皮前体细胞(EPCs)在成人外周血中已被发现。我们研究了内皮祖细胞是否可以从脐带血(造血祖细胞的丰富来源)中分离,以及内皮祖细胞的体内移植是否可以调节出生后的新生血管形成。脐带血单个核细胞(MNCs)培养后可形成大量细胞簇、梭形和贴壁(AT)细胞以及索状结构。示踪实验显示,细胞簇、AT细胞和索状结构主要来源于CD 34阳性MNC(MNC <CD 34 +>)。更多数量的AT细胞和细胞簇从脐带血-MNCs比从等量的成人外周血-MNCs。AT细胞掺入乙酰化LDL,释放一氧化氮,并表达KDR,VE-钙粘蛋白,CD 31和血管性血友病因子,但不表达CD 45。局部移植的AT细胞在免疫缺陷裸鼠缺血组织中存活并参与毛细血管网络。因此,AT细胞具有多种内皮表型,并被定义为EPCs的主要群体。此外,激光多普勒和免疫组化分析显示,EPC移植定量增加缺血后肢的新血管形成和血流。总之,脐带血是分离内皮祖细胞的宝贵来源,脐带血来源的内皮祖细胞的移植将是一种新的策略,以调节出生后的新生血管。

项目成果

期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T.: "Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery
Urano H、Ikeda H、Ueno T、Matsumoto T、Murohara T、Imaizumi T.:“增强体外反搏可改善冠状动脉患者的运动耐量、减少运动引起的心肌缺血并改善左心室舒张期充盈
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Murohara T, Ikeda H, Duan J, Shintani S, Sasaki Ki, Eguchi H, Onitsuka I, Matsui K, Imaizumi T.: "Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization."J Clin Invest. 105. 1527-1536 (2000)
Murohara T、Ikeda H、Duan J、Shintani S、Sasaki Ki、Eguchi H、Onitsuka I、Matsui K、Imaizumi T.:“移植的脐带血来源的内皮前体细胞增强了产后新生血管形成。”J Clin Invest。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ikeda H,Ueyama T,Murohara T,et al.: "Adhesive interaction between P-selectin and sialyl lewisX plays an important role in recurrent coronary arterial thrombosis in dogs."Arterioscler.Thromb.Vasc.Biol.. 19. 1083-1090 (1999)
Ikeda H、Ueyama T、Murohara T 等人:“P-选择素和唾液酸 lewisX 之间的粘附相互作用在狗的复发性冠状动脉血栓形成中发挥着重要作用。”Arterioscler.Thromb.Vasc.Biol.. 19. 1083-1090
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Duan J, Murohara T, Ikeda H, Sasaki Ki, Shintani S, Akita T, Shimada T, Imaizumi T.: "Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia."Arterioscler Thromb Vasc Biol. 20. 2579-2585 (2000)
Duan J、Murohara T、Ikeda H、Sasaki Ki、Shintani S、Akita T、Shimada T、Imaizumi T.:“高同型半胱氨酸血症会损害后肢缺血反应中的血管生成。”动脉硬化血栓血管生物学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T.: "Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability."J Am Coll Cardiol. (in press). (200
Takajo Y、Ikeda H、Haramaki N、Murohara T、Imaizumi T.:“慢性吸烟者血小板氧化应激增强。血小板源性一氧化氮生物活性受损和血小板聚集性增强的机制。”J Am Coll Cardiol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MUROHARA Toyoaki其他文献

Midkine gene transfer ameliorates ischemic cardiomyopathy through enhancements of neovascularization via Akt/PI3 kinase and ERK Rathways and anti-apoptosis by regulating Bcl-2 and bax.
Midkine 基因转移通过 Akt/PI3 激酶和 ERK Rathways 增强新血管形成,并通过调节 Bcl-2 和 bax 抗细胞凋亡,从而改善缺血性心肌病。
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    SUMIDA Arihiro;HORIBA Mitsuru;ISHIGURO Hisaaki;TAKENAKA Hiroharu;UEDA Norihiro;LEE Jong-Kook;MUROHARA Toyoaki;KADOMATSU Kenji;KODAMA Itsuo
  • 通讯作者:
    KODAMA Itsuo
The Diagnostic Value of the QWave Amplitude Ratio in Lead aVR for Differentiating the Outflow Tract Ventricular Arrhythmia Origin
aVR导联Q波幅值比对鉴别流出道室性心律失常起源的诊断价值
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    YOSHIDA Naoki、INDEN Yasuya;YAMAMOTO Toshihiko;OHGUCHI Shiou;MIYATA Shinjiro;TAGUCHI Noriko;FUJITA Masaya;YOKOI Kenichiro;KUMAGAI Soichiro;SHIMANO Masayuki;HIRAI Makoto;MUROHARA Toyoaki
  • 通讯作者:
    MUROHARA Toyoaki
Midkine gene transfer ameliorates ischemic cardiomyopathy through enhancements of neovascularization via Akt/PI3 kinase and ERK pathways and anti-apoptosis by regulating Bcl-2 and bax
Midkine 基因转移通过 Akt/PI3 激酶和 ERK 途径增强新血管形成,并通过调节 Bcl-2 和 bax 抗细胞凋亡,从而改善缺血性心肌病
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    SUMIDA Arihiro;HORIBA Mitsuru;ISHIGURO Hisaaki;TAKENAKA Hiroharu;UEDA Norihiro;LEE Jong-Kook;MUROHARA Toyoaki;KADOMATSU Kenji;KODAMA Itsuo
  • 通讯作者:
    KODAMA Itsuo
添付文書を介したリスクコミュニケーション
通过说明书进行风险沟通
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    YOSHIDA Naoki、INDEN Yasuya;YAMAMOTO Toshihiko;OHGUCHI Shiou;MIYATA Shinjiro;TAGUCHI Noriko;FUJITA Masaya;YOKOI Kenichiro;KUMAGAI Soichiro;SHIMANO Masayuki;HIRAI Makoto;MUROHARA Toyoaki;齋藤充生
  • 通讯作者:
    齋藤充生
The Predictor of Left Atrial Appendage Dysfunction in Patients with CHADS2 Score of 0
CHADS2 评分为 0 的患者左心耳功能障碍的预测因子
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    YOSHIDA Naoki、INDEN Yasuya;YAMAMOTO Toshihiko;OHGUCHI Shiou;MIYATA Shinjiro;TAGUCHI Noriko;FUJITA Masaya;YOKOI Kenichiro;KUMAGAI Soichiro;SHIMANO Masayuki;HIRAI Makoto;MUROHARA Toyoaki
  • 通讯作者:
    MUROHARA Toyoaki

MUROHARA Toyoaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MUROHARA Toyoaki', 18)}}的其他基金

Role of diseased angiogenesis in diabetic cardiomyopathy and its significance for the invention of novel therapeutic strategy.
病变血管生成在糖尿病心肌病中的作用及其对发明新治疗策略的意义。
  • 批准号:
    20249045
  • 财政年份:
    2008
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Investigation of the molecular mechanism of progenitor cell-mediated therapeutic angiogenesis
祖细胞介导的治疗性血管生成的分子机制研究
  • 批准号:
    18390232
  • 财政年份:
    2006
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Therapeutic angiogenesis using noble human VEGF-E chimeric genes and autologous bone marrow mononuclear cells
使用高贵的人 VEGF-E 嵌合基因和自体骨髓单核细胞进行治疗性血管生成
  • 批准号:
    16390221
  • 财政年份:
    2004
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic research for the purpose of better outcome of therapeutic angiogenesis by cell tansplantation
旨在通过细胞移植获得更好的治疗性血管生成效果的基础研究
  • 批准号:
    14370235
  • 财政年份:
    2002
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of therapeutic angiogenesis using peripheral blood stem cells
使用外周血干细胞开发治疗性血管生成
  • 批准号:
    12470161
  • 财政年份:
    2000
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Operating Grants
Mechanisms of Atrial and Ventricular Mechano-arrhythmogenesis in Ischemic Heart Disease
缺血性心脏病心房和心室机械性心律失常发生机制
  • 批准号:
    478147
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Operating Grants
The Effect of Coronary Revascularization Treatment Timing on Mortality in Patients with Stable Ischemic Heart Disease in British Columbia
冠状动脉血运重建治疗时机对不列颠哥伦比亚省稳定型缺血性心脏病患者死亡率的影响
  • 批准号:
    495416
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Dissecting the functional roles of cardiac lymphatics in ischemic heart disease
剖析心脏淋巴管在缺血性心脏病中的功能作用
  • 批准号:
    10585972
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Genetic Associations of Ischemic Heart Disease and Symptoms Among Diverse Postmenopausal Women
不同绝经后妇女缺血性心脏病和症状的遗传关联
  • 批准号:
    10625393
  • 财政年份:
    2022
  • 资助金额:
    $ 8.64万
  • 项目类别:
Genetic Associations of Ischemic Heart Disease and Symptoms Among Diverse Postmenopausal Women
不同绝经后妇女缺血性心脏病和症状的遗传关联
  • 批准号:
    10450934
  • 财政年份:
    2022
  • 资助金额:
    $ 8.64万
  • 项目类别:
Establishment of nursing intervention for sleep to improve lifestyle in patients with ischemic heart disease
改善缺血性心脏病患者生活方式的睡眠护理干预措施的建立
  • 批准号:
    22K10837
  • 财政年份:
    2022
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of Atrial and Ventricular Mechano-arrhythmogenesis in Ischemic Heart Disease
缺血性心脏病心房和心室机械性心律失常发生机制
  • 批准号:
    477259
  • 财政年份:
    2022
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Operating Grants
Improved cardiac T1 reactivity measures for gadolinium-free MRI assessment of ischemic heart disease
改进心脏 T1 反应性测量,用于缺血性心脏病的无钆 MRI 评估
  • 批准号:
    10705358
  • 财政年份:
    2022
  • 资助金额:
    $ 8.64万
  • 项目类别:
Slowing Atherothrombosis Progression through Indoor Air Filtration: A Crossover Trial in Hispanic and non-Hispanic Adults with Ischemic Heart Disease History
通过室内空气过滤减缓动脉粥样硬化血栓形成的进展:对有缺血性心脏病史的西班牙裔和非西班牙裔成年人进行的交叉试验
  • 批准号:
    10688095
  • 财政年份:
    2022
  • 资助金额:
    $ 8.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了